Study on the change of neutralizing antibody level in plasma donors after a third shot of inactivated novel coronavirus vaccine
Journal Title: Chinese Journal of Blood Transfusion - Year 2023, Vol 36, Issue 5
Abstract
Objective To investigate the trend of neutralizing antibody level in plasma donors who received the 3rd shot of inactivated novel coronavirus vaccine. Methods Three commercial ELISA kits for novel coronavirus neutralization antibody detection, manufactured by Company A, B and C, were chosen and screened by Pseudotype Neutralization Test from December 2021 to June 2022. A total of 410 plasma samples from 64 plasma donors who received the 3rd shot of inactivated novel coronavirus vaccine and there after donated plasma within six months were detected by the selected ELISA kit from July to October, 2022. The data were analyzed by Excel 2013 and SPSS 26 software. Results The high-throughput ELISA kit for SARS-CoV-2 neutralizing antibody detection, manufactured by Company A, was selected for further antibody titer detection. The mixed plasma titers were 1 337.34, 1 148.89, 852.19, 681.38, 556.44 and 457.19 U/mL from 1 to 6 months, respectively, after the 3rd shot of vaccine. The neutralizing antibody titer level began to increase around 7 days after the 3rd shot of vaccine injection and peaked (peak range: 264.07-2 208.39 U/mL, median: 569.34 U/mL) at 1 month (range: 9-43 days, median: 22 days), and then gradually decreased (P<0.05). Conclusion The neutralizing antibody titer of plasma donors who received the 3rd shot of inactivated novel coronavirus vaccine began to rise around 7 days after vaccination, which reached the peak value at around 1 month and then gradually decreased.
Authors and Affiliations
Wenjuan GE, An ZHOU, Junying SHEN, Xiaoqing LI, Jie MA, Mengzhao ZHU, Changyong JIAN
Keywords
Related Articles
- EP ID EP738545
- DOI 10.13303/j.cjbt.issn.1004-549x.2023.05.009
- Views 72
- Downloads 0
Retest improvement for minipool nucleic acid testing positive samples
Objective To analyze the correlation between the distribution interval of minipool nucleic acid testing(NAT) positive CT value and the resolution rate, so as to improve the retest model and reduce residual risk of blood...
Clinical application of thrombelastogram and reference interval for our laboratory
Objective To respectively analyze the application of thrombogram (TEG) in our hospital and explore the reference interval for our laboratory. Methods Healthy adults who underwent physical examination in our hospital from...
Molecular mechanism and bioinformatics analysis of 9 samples with rare RhD variants
Objective To study the molecular mechanism of 9 samples with rare RhD variants and their RhD epitopes and protein structure. Methods The 9 blood samples with rare RhD variants were collected from 210 644 blood donors of...
ABO blood group screening results among blood donors in Guangzhou from 2021 to 2022
Objective To investigate the distribution of ABO and RhD blood groups among voluntary blood donors in Guangzhou, in order to ensure clinical blood safety and better serve blood donors. Methods Routine ABO and RhD blood g...
Effect of long-term frozen plasma on the detection of HBsAg by ELISA
Objective To evaluate the HBsAg detection results of HBsAg+ samples after 8 years refrigeration by ELISA and evaluate the effectiveness of the current storage policy of retained samples. Methods A total of 100 HBsAg+ pla...